Friday, 21 January, 2022
TopicCentral Drugs Standard Control Organization

Topic: Central Drugs Standard Control Organization

Pune cell science centre could soon get Modi govt nod to test and approve Covid vaccines

If given a go-ahead, National Centre for Cell Science will be the 2nd centre after Central Drugs Laboratory, Kasauli, to test Covid-19 vaccines.

Roche India gets nod for emergency use of Casirivimab, Imdevimab for Covid treatment

The antibody cocktail is to be used for the treatment of mild to moderate Covid in adults and pediatric patients with a high risk of severe symptoms, Roche said in a statement.

Why India’s expert panel rejected Pfizer plea for emergency use nod to its Covid vaccine

The Drug Controller General of India has in the past rejected several applications from other drugmakers, including Dr Reddy Laboratory and Natco Pharma.

Govt panel rejects emergency-use approval for Dr Reddy’s Russian-origin potential Covid drug

The company had requested for waiver of clinical trials in India as a condition to market the monoclonal, antibody-based drug, Olokizumab.

Govt begins internal review of Pfizer and Serum Covid vaccines, focus on safety & quality

The recommendations on granting of authorisation will be made on three parameters — safety, quality and efficacy. The Drug Controller General of India will take the final decision.

Hand sanitiser makers under govt scanner after complaints of ‘substandard’ products

Govt has collected samples of all kinds of hand sanitisers — from local products to top selling brands such as Dettol, Himalaya, Godrej, Savlon — for quality check.

India could be producing over 20,000 vials of Remdesivir per day by month-end: Govt data

Remdesivir is now being manufactured by Cipla, Hetero Labs and Mylan. Cipla Wednesday launched the drug under the brand name Cipremi.

After complaint, Modi govt asks states to keep vigil to stop ‘black-marketing’ of remdesivir

The order comes after the govt received a complaint from LocalCircles, saying the drug, whose MRP is Rs 5,400, is being sold at a price of between Rs 15,000 and Rs 60,000. 

Hetero Labs in Hyderabad seeks nod from govt to market remdesivir, a potential Covid drug

Hetero Labs filed an application with the Central Drugs Standard Control Organisation (CDSCO) last week. The CDSCO may soon reach out to ICMR for suggestions.

Himachal govt to file FIR against cough syrup makers ‘responsible’ for 10 infant deaths 

The Coldbest-PC cough syrup, manufactured by the Himachal-based Digital Vision firm, has allegedly led to deaths of 9 infants in J&K and one in Haryana. 

On Camera

YourTurn

How Facebook and Amazon rely on an invisible workforce

The market for on-demand, digital tasks is estimated by the World Bank to be worth $25 billion, with Meta Platforms, Amazon, YouTube as some of the biggest buyers.
Representational image of a jewellery store | ANI

India Jewellery Park to be set up in Mumbai, aims to attract Rs 20,000 crore investment

The Gem & Jewellery Export Promotion Council and Maharashtra Industrial Development Corporation have signed a draft agreement granting possession of a plot for setting up the park.

Defence

Foreign secretary Harsh Vardhan Shringla meets German Navy chief Vice Admiral Kay-Achim Schönbach on 20 January. | Twitter | @MEAIndia

New chapter in ties as Indian foreign secy meets Germany navy chief, warship ‘Bayern’ visits

With Germany identifying India as one of the key partners in its Indo-Pacific policy, a German frigate entered Indian waters for a port call in Mumbai, in a major signal to China.
Illustration by Soham Sen | ThePrint

Read my lips, I’m hurting, says Pakistan’s National Security Policy. What it means for India

The new policy is mostly chaff, but it reveals the most inward-looking Pakistan in 3 decades. It needs breathing space, and is realising loss of stature and friendship with US.
×